Weather threats to drug production facilities examined in study
A JAMA study published Aug. 20 found that nearly 63% of all U.S. drug production facilities from 2019 through 2024 were in counties where a weather disaster declaration was declared. About 34% of facilities were in such areas annually during the study period. Researchers said the findings demonstrate an urgent need for supply chain transparency, strategic allocation of production, and disaster risk management strategies to prevent future health care disruptions in the U.S.
Related News Articles
Headline
The Administration for Strategic Preparedness and Response announced March 5 that it will invest in the domestic production of thebaine, an ingredient…
Headline
The Supreme Court Feb. 20 ruled that the International Emergency Economic Powers Act does not authorize the imposition of global tariffs. The court held that…
Headline
The AHA Feb. 18 responded to a request for information from Reps. Neal Dunn, R-Fla., and Lori Trahan, D-Mass., on the potential reauthorization of the Pandemic…
Headline
The measles outbreak in South Carolina has increased to 876 cases, the state’s Department of Public Health reported Feb. 3. Last week, the South Carolina…
Headline
Two AHA guides offer strategies for hospitals and health systems in preparing for public health emergencies and disasters and managing cybersecurity incidents…
Headline
The Centers for Medicare & Medicaid Services Jan. 26 released an advanced notice of proposed rulemaking seeking comments on potential future policies to…